SAN FRANCISCO — An eye drop improved visual acuity in patients with diabetic macular edema, according to a study presented at Retina Subspecialty Day at the American Academy of Ophthalmology meeting.
“OCS-01 is aiming to be the first eye drop developed for the treatment of diabetic macular edema,” Hani Salehi-Had, MD, said.
Salehi-Had said it is based on Optireach technology to deliver dexamethasone to the eye in a hydrophilic eye drop.
In the DIAMOND trial, patients with DME were randomly assigned to receive either OCS-01 (Oculis) (100 patients) or vehicle (48 patients).